EUVIMEDEUVIMED entdecken
LeserbriefRandomisierte kontrollierte Studie

Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”

Yongjian Lin iD

Circulation · 2024

DOI: 10.1161/circulationaha.123.067391 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Circulation, 2024. Verfasst von Yongjian Lin. Beteiligte Einrichtung: Department of Gastrointestinal and Gland Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Vitamin K, Frail Elderly. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsVitamin KFrail ElderlyHumansAgedAdministration, OralRandomized Controlled Trials as TopicDrug SubstitutionAged, 80 and over

Substanzen

AnticoagulantsVitamin K

Autor:innen und Institutionen

  • Department of Gastrointestinal and Gland Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.

ORCID-Profile: Yongjian Lin

Zitieren

APA

Lin, Y. (2024). Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. https://doi.org/10.1161/circulationaha.123.067391

Vancouver

Lin Y. Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. 2024. doi:10.1161/circulationaha.123.067391

BibTeX
@article{Lin2024,
  author = {Lin, Yongjian},
  title = {Letter by Lin Regarding Article, “Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.123.067391}
}
Kostenlos starten →